Cardiovascular Devices Market Set to Grow fromUSD61.82Billionin2025 toUSD78.78Billion by2030, Driven by AI-Enabled Diagnostics and Minimally Invasive Therapies

Mordor Intelligence has published a new report on the Cardiovascular Devices Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction

Mordor Intelligence, in its latest Cardiovascular Devices Market report, forecasts a market value of USD78.78billion by 2030 from USD61.82billion in 2025, at a healthy 4.97% CAGR. Highlighting rising demand for AI-based diagnostic tools, expanding structural heart device use, and the shift towards outpatient cardiac interventions. The cardiovascular devices market [https://www.mordorintelligence.com/industry-reports/global-cardiovascular-devices-market-industry?utm_source=abnewswire] encompasses a broad range of medical tools and equipment used in the diagnosis, monitoring, and treatment of heart and blood vessel related conditions.

Key Trends

The cardiovascular devices sector is evolving on multiple fronts:

*
AI-powered diagnostics and remote monitoring: Diagnostic and monitoring devices already account for over 72% of the market share in 2024. With improvements in predictive analytics and AI-enhanced ECG, and remote monitoring platforms, healthcare providers can detect arrhythmias and other cardiac conditions earlier and more accurately.

*
Expansion of structural heart interventions: Structural heart devices, including transcatheter aortic valve replacement (TAVR), mitral, and tricuspid valve devices, are gaining traction. This segment boasts one of the highest growth rates, with the broader structural heart devices market expected to grow at around 9.24% CAGR to USD21.48billion by 2030. Manufacturers continue to launch newer, user-friendly systems aimed at low risk and outpatient treatments.

*
Surge in minimally invasive and ASC procedures: Therapeutic devices, such as those used in interventional cardiology, are anticipated to grow at a robust 6.97% CAGR through 2030. In parallel, ambulatory surgical centers are forecast to register the fastest revenue growth (9.86% CAGR) as more cardiac procedures move out of traditional hospital settings.

*
Strategic landscape reshaping: Leading market players are consolidating through acquisitions to broaden their cardiovascular portfolios. Alongside regulatory approvals for instance, for leadless pacemakers or renal denervation systems, these strategies are expanding addressable markets. However, adoption is moderated by regulatory complexities and the capital intensity of advanced technology.

*
Regional growth dynamics: North America remains the dominant market with approximately 45% revenue share in 2024. Notably, Asia Pacific is emerging as the fastest growing region, projected to expand at nearly 8.96% CAGR.

Market Segmentation

By Device Type

Diagnostic & Monitoring Devices

*
Includes electrocardiogram (ECG) machines, remote cardiac monitoring systems, and various other diagnostic tools.

*
This segment dominated revenue in 2024 with approximately 72.2% share, highlighting its leading role in early detection and continuous tracking of heart conditions.

Therapeutic & Surgical Devices

*
Covers a wide array of treatment tools: cardiac assist devices, rhythm management implants (like pacemakers), catheters, grafts, heart valves, stents, and other surgical apparatus.

*
Although smaller now, this category is growing faster estimated at a 6.97% CAGR through 2030, as interventional procedures and surgical therapies see increasing adoption.

By Application

Coronary Artery Disease

*
Holds the largest application share nearly 45.0% in 2024 due to the persistent global burden of ischemic heart conditions.

Arrhythmia; Heart Failure; Structural Heart Disease; Hypertension; Others

*
Among these, structural heart disease (e.g., valvular disorders, septal defects) is a standout: expected to expand at approximately 7.8% CAGR by 2030, driven by greater adoption of therapies like TAVR and TMVR.

By EndUser

Hospitals & Cardiac Centers

*
Capture roughly 59.2% of the market in 2024. These institutions rely heavily on both diagnostic tools and therapeutic devices and remain the central hubs for cardiac care.

Ambulatory Surgical Centers (ASCs)

*
Represent the fastest growing channel, with an anticipated 9.86% CAGR through 2030. As more procedures migrate out of traditional hospitals, ASCs are rising to prominence.

Other Channels

*
This includes home care settings and specialty clinics, which are becoming increasingly relevant for monitoring and post procedure follow up, especially as remote health technologies become mainstream.

By Geography

North America

*
The largest regional market in 2024 commanded around 45.24% of global market revenue.

Europe; Middle East & Africa; South America

*
Europe ranks second, with key players like Germany and the UK moving forward under sophisticated regulatory systems

AsiaPacific

*
The fastest growing region, projected at nearly 8.96% CAGR from 2025 to 2030. Growth is fueled by rising cardiovascular disease prevalence, expanding middle class healthcare access, and investments in medical infrastructure

Key Players

The cardiovascular devices market is shaped by a mix of global leaders and specialized innovators:

*
Boston Scientific A global provider with a wide-ranging portfolio in cardiovascular devices. Known for drugeluting stents, catheters, electrophysiology tools, and implantable cardiac devices, Boston Scientific ranks among the top five companies in the cardiovascular devices market.

*
Abbott Laboratories A major player across multiple cardiovascular segments including diagnostic tools, interventional products, and implantable devices. Abbott consistently ranks among the market leaders listed in the report.

*
Medtronic One of the largest medical technology companies worldwide, Medtronic drives innovation in pacemakers, defibrillators, cardiac monitoring systems, and minimally invasive therapies. It is repeatedly cited as a leading competitor in the cardiovascular devices space.

*
Edwards Lifesciences Specializes in heart valve technologies both surgical and transcatheter as well as hemodynamic monitoring. Ranked among the top five cardiovascular device companies.

*
Cardinal Health Recognized as one of the top five firms in the market; the company provides a diverse range of cardiac surgical supplies, monitoring tools, and interventional products

Conclusion

By 2030, the cardiovascular devices landscape is expected to transition significantly:

*
Diagnostic and remote monitoring tools will maintain dominance, supported by AI driven platforms and wearable technology. Such innovation will drive earlier detection, enhanced patient care, and reduced hospital admissions.

*
Structural and interventional procedures will continue to migrate to outpatient settings. ASCs and low risk valve replacements via TAVR and TMVR will gain even broader acceptance, particularly as clinical data accrues and reimbursement frameworks adjust.

*
Emerging markets in Asia-Pacific will undergo rapid expansion as healthcare systems upgrade infrastructure and adopt sophisticated yet affordable cardiovascular technologies, hastening the market's overall shift.

*
Strategic investments will accelerate industry consolidation. Continuous effort in regulatory approvals, especially implantable and leadless devices, will serve as growth catalysts. Although the high cost and regulatory oversight may delay adoption in some regions, overall market expansion remains compelling.

In sum, the cardiovascular devices market is projected to grow from USD61.82billion in 2025 to USD78.78billion by 2030, reinforcing its importance in modern cardiology care. The combined momentum from AI-powered diagnostics, structural heart innovation, and shifting care settings promises to deliver enhanced patient outcomes and ongoing market opportunity provided manufacturers navigate regulatory pathways and cost constraints successfully.

Industry Related Reports

India Cardiovascular Devices Market: [https://www.mordorintelligence.com/industry-reports/india-cardiovascular-devices-market-growth?utm_source=abnewswire] The India Cardiovascular Devices Market is categorized based on device type into two main segments: diagnostic and monitoring devices, and therapeutic and surgical devices. The diagnostic and monitoring segment includes technologies such as electrocardiograms (ECGs), remote cardiac monitoring systems, and other tools used for early detection and continuous tracking of heart conditions. The therapeutic and surgical devices segment covers products like cardiac assist devices, cardiac rhythm management devices, and various types of catheters, all aimed at treating and managing cardiovascular diseases through surgical or minimally invasive procedures.

Spain Cardiovascular Devices Market: The Spain Cardiovascular Devices Market report is segmented by device type into diagnostic and monitoring devices, and therapeutic and surgical devices. The diagnostic and monitoring category includes electrocardiograms (ECGs), remote cardiac monitoring systems, and other related diagnostic tools used to assess and track heart health. The therapeutic and surgical segment comprises a wide range of devices such as cardiac assist devices, cardiac rhythm management devices, catheters, stents and grafts, heart valves, and additional tools used in the treatment and surgical management of cardiovascular conditions.

Get More insights: https://www.mordorintelligence.com/industry-reports/spain-cardiovascular-devices-market?utm_source=abnewswire

China Cardiovascular Devices Market: [https://www.mordorintelligence.com/industry-reports/china-cardiovascular-devices-market?utm_source=abnewswire] The China Cardiovascular Devices Market is segmented by device type into diagnostic and monitoring devices, as well as therapeutic and surgical devices. Within the diagnostic and monitoring category, the market includes tools such as electrocardiograms (ECGs), remote cardiac monitoring systems, and other technologies used for heart condition detection and patient monitoring. The therapeutic and surgical segment features devices like cardiac assist systems, cardiac rhythm management devices, catheters, and additional equipment used in the treatment and surgical intervention of cardiovascular diseases.

About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cardiovascular-devices-market-set-to-grow-fromusd6182billionin2025-tousd7878billion-by2030-driven-by-aienabled-diagnostics-and-minimally-invasive-therapies]
Phone: +1 617-765-2493
Address:5th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.